[Surgical approaches to interventricular septum in hypertrophic cardiomyopathy]

A V Lysenko1, G I Salagaev1, P V Lednev1

  • 1Petrovsky National Research Center of Surgery, Moscow, Russia.

Khirurgiia
|December 23, 2021
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) involves heart muscle thickening. This review details surgical approaches for interventricular septum issues in HCM patients, emphasizing personalized treatment for better outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is an inherited heart muscle disease.
  • It causes thickening of the heart's ventricular walls and interventricular septum.
  • HCM is not caused by valve issues or external factors.

Purpose of the Study:

  • To review surgical approaches for interventricular septum in HCM.
  • To address different locations of left ventricular obstruction.
  • To highlight the importance of personalized surgical strategies.

Main Methods:

  • Review of existing literature on surgical techniques for HCM.
  • Analysis of different phenotypic variants of HCM.
  • Discussion of surgical approaches based on obstruction localization.

Main Results:

  • Various surgical techniques exist for addressing interventricular septum hypertrophy.
  • The choice of approach depends on the specific location and pattern of hypertrophy.
  • Personalized surgical strategies are crucial for optimal patient outcomes.

Conclusions:

  • Tailored surgical interventions are necessary for effective HCM management.
  • Understanding diverse surgical options improves postoperative results.
  • Minimizing complications requires individualized treatment plans for HCM patients.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
42
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
53
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
47
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60